Availability (in Japan)
10 or more
(In Japan at 17:00,
Oct 8, 2024 in JST)
Size
100 µL (1 mg/mL)
Data | |||||
---|---|---|---|---|---|
Clonality | Monoclonal | Clone | 27A2 | ||
Isotype (Immunized Animal) | Mouse IgG2b | ||||
Applications | |||||
Immunogen (Antigen) | Recombinant Human PD-L1 extracellular domain | ||||
Reactivity [Gene ID] | Human[29126] |
||||
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | ||||
Storage temp. | -20°C | Conjugate | Unlabeled | Manufacturer | MBL |
Alternative names | B7H1 | ||||
Background | Programmed death ligand 1 (PD-L1, also known as CD274/B7-H1), a member of B7 family was identified by searching for molecules that share homology with the immunogloblin V and C domains of B7-1 and B7-2 among the human cDNA expressed sequence tags in the National Center for Biotechnology Information database. PD-L1 is a ligand for programmed death 1 (PD-1) which belongs to the CD28/CTLA4 subfamily. Although <em>in vitro</em> study indicated that the cross-linking of PD-1 by PD-L1 leads to down-regulation of T-cell responses, some studies have shown that T cells stimulated with low levels of anti-CD3 and immobilized PD-L1-Ig were activated, proliferation and production of IFN-γ GM-CSF and IL-10 from the T cells were enhanced. The role of PD-L1 is now debatable. | ||||
Related products | D230-5 Anti-CD274 (PD-L1) (Human) mAb-PE D092-3M2 Anti-CD274 (PD-L1) (Human) mAb (Functional Grade) D133-3M2 Anti-CD279 (PD-1) (Human) mAb (Functional Grade) D092-3 Anti-CD274 (PD-L1) (Human) mAb D132-3 Anti-CD279 (PD-1) (Human) mAb D132-4 Anti-CD279 (PD-1) (Human) mAb-FITC D132-5 Anti-CD279 (PD-1) (Human) mAb-PE D133-5 Anti-CD279 (PD-1) (Human) mAb-PE |
||||
Citations |
Immunohistochemistry
|
||||
Product category |
|